One the most common New Year resolutions is to lose weight. Weight loss could be a more achievable prospect 2024 because recently-approved injectable drugs that have proven to be particularly effective helping people shed the kilos (or pounds). They belong to a class medications called GLP-1. The most well known these are Wegovy and Ozempic. The drugs.com website reported that extensive studies of patients using Wegovy, 83 per cent of participants lost 5 per cent or more their weight compared to 31 per cent of those taking a placebo. A cardiologist the Mayo Clinic said obesity drugs "are here to stay" and that "more and more these drugs are coming to the market".
The significance of the new remedies has been highlighted industry experts. The prestigious journal "Science" declared the family weight-loss drugs to be medicine's "breakthrough the year" for 2023. This year could prove to be even better overweight people, and those who find exercising difficult. A new drug called Zepbound has been approved. clinical trials, people taking this lost an average of 20-25 per cent their weight. Obesity specialist, doctor Juliana Simonetti, said the new drugs were "amazing, since they address the underlying physiological cause weight regain". She added: "I've been working this field the last decade, and the results are very impressive."
